$0.000001
At close: Feb 18, 9:30 AM EDT
Comments
Loading...
Black Bird Biotech Analyst Ratings and Price Targets | OTC:BBBT | Benzinga
Black Bird Biotech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Black Bird Biotech Corp from these most-recent analyst ratings.
Analyst Ratings for Black Bird Biotech
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Black Bird Biotech (BBBT) stock?
There is no price target for Black Bird Biotech
What is the most recent analyst rating for Black Bird Biotech (BBBT)?
There is no analyst for Black Bird Biotech
When was the last upgrade for Black Bird Biotech (BBBT)?
There is no last upgrade for Black Bird Biotech
When was the last downgrade for Black Bird Biotech (BBBT)?
There is no last downgrade for Black Bird Biotech.
When is the next analyst rating going to be posted or updated for Black Bird Biotech (BBBT)?
There is no next analyst rating for Black Bird Biotech.
Is the Analyst Rating Black Bird Biotech (BBBT) correct?
There is no next analyst rating for Black Bird Biotech.
Browse analyst ratings and price targets on all stocks.